{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:20:45Z","timestamp":1791328845826,"version":"4.3.1"},"reference-count":92,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.hlc.2013.01.006","type":"journal-article","created":{"date-parts":[[2013,2,9]],"date-time":"2013-02-09T22:14:30Z","timestamp":1360448070000},"page":"412-420","source":"Crossref","is-referenced-by-count":11,"title":["The Renaissance of Primary Aldosteronism: What Has it Taught Us?"],"prefix":"10.1016","volume":"22","author":[{"given":"Michael","family":"Stowasser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard Douglas","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hlc.2013.01.006_bib0005","first-page":"257","article-title":"The evolution of primary aldosteronism: 1954\u20131967","volume":"62","author":"Conn","year":"1966","journal-title":"Harvey Lect"},{"key":"10.1016\/j.hlc.2013.01.006_bib0010","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1001\/archsurg.1996.01430180072015","article-title":"Factors influencing outcome of surgery for primary aldosteronism","volume":"131","author":"Celen","year":"1996","journal-title":"Arch Surg"},{"key":"10.1016\/j.hlc.2013.01.006_bib0015","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s002689900552","article-title":"Success of surgery for primary aldosteronism judged by residual autonomous aldosterone production","volume":"22","author":"Rutherford","year":"1998","journal-title":"World J Surg"},{"key":"10.1016\/j.hlc.2013.01.006_bib0460","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1210\/jc.2009-1763","article-title":"Improvement in quality of life as well as in blood pressure and biochemical status following laparoscopic adrenalectomy in patients with unilateral primary aldosteronism \u2013 a pilot study","volume":"95","author":"Sukor","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.hlc.2013.01.006_bib0025","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00004872-200103000-00001","article-title":"A review of the medical treatment of primary aldosteronism","volume":"19","author":"Lim","year":"2001","journal-title":"J Hypertens"},{"key":"10.1016\/j.hlc.2013.01.006_bib0030","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1097\/00004872-200311000-00025","article-title":"High rate of detection of primary aldosteronism, including surgically treatable forms, after \u2018non-selective\u2019 screening of hypertensive patients","volume":"21","author":"Stowasser","year":"2003","journal-title":"J Hypertens"},{"key":"10.1016\/j.hlc.2013.01.006_bib0035","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1046\/j.1365-2125.1999.00070.x","article-title":"Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: a prospective cohort follow-up study","volume":"48","author":"Lim","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.hlc.2013.01.006_bib0040","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/archinte.1981.00340130033011","article-title":"A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients","volume":"141","author":"Hiramatsu","year":"1981","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.hlc.2013.01.006_bib0045","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0140-6736(92)93225-C","article-title":"Primary aldosteronism: hypertension with a genetic basis","volume":"340","author":"Gordon","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.hlc.2013.01.006_bib0050","series-title":"Textbook of hypertension","first-page":"865","article-title":"Primary aldosteronism and other forms of mineralocorticoid hypertension","author":"Gordon","year":"1994"},{"key":"10.1016\/j.hlc.2013.01.006_bib0055","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mce.2003.10.006","article-title":"Primary aldosteronism-careful investigation is essential and rewarding","volume":"217","author":"Stowasser","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.hlc.2013.01.006_bib0060","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1440-1681.1994.tb02519.x","article-title":"High incidence of primary aldosteronism in 199 patients referred with hypertension","volume":"21","author":"Gordon","year":"1994","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.hlc.2013.01.006_bib0065","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1440-1681.1993.tb01687.x","article-title":"Evidence that primary aldosteronism may not be uncommon: 12% incidence among antihypertensive drug trial volunteers","volume":"20","author":"Gordon","year":"1993","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.hlc.2013.01.006_bib0070","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1210\/jc.85.5.1863","article-title":"Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology","volume":"85","author":"Fardella","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.hlc.2013.01.006_bib0075","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/sj.jhh.1001013","article-title":"High prevalence of primary aldosteronism in the Tayside hypertension clinic population","volume":"14","author":"Lim","year":"2000","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.hlc.2013.01.006_bib0080","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1210\/jc.85.8.2854","article-title":"Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore","volume":"85","author":"Loh","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.hlc.2013.01.006_bib0085","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents","volume":"89","author":"Mulatero","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.hlc.2013.01.006_bib0090","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1291\/hypres.30.103","article-title":"Is primary aldosteronism rare or common among hypertensive patients?","volume":"30","author":"Nishikawa","year":"2007","journal-title":"Hypertens Res"},{"key":"10.1016\/j.hlc.2013.01.006_bib0095","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2013.01.006_bib0100","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00019616-199707040-00003","article-title":"Primary aldosteronism: update on diagnosis and treatment","volume":"7","author":"Young","year":"1997","journal-title":"Endocrinologist"},{"key":"10.1016\/j.hlc.2013.01.006_bib0105","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","article-title":"Hyperaldosteronism among black and white subjects with resistant hypertension","volume":"40","author":"Calhoun","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.hlc.2013.01.006_bib0110","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1097\/00004872-200411000-00026","article-title":"Low-renin status in therapy-resistant hypertension: a clue to efficient treatment","volume":"22","author":"Eide","year":"2004","journal-title":"J Hypertens"},{"key":"10.1016\/j.hlc.2013.01.006_bib0115","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0272-6386(01)80117-7","article-title":"Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone\u2013renin ratio","volume":"37","author":"Gallay","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.hlc.2013.01.006_bib0120","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/sj.jhh.1001554","article-title":"Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe region","volume":"17","author":"Strauch","year":"2003","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.hlc.2013.01.006_bib0125","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1177\/000313480507101015","article-title":"Long-term results of adrenalectomy in patients with aldosterone-producing adenomas: multivariate analysis of factors affecting unresolved hypertension and review of the literature","volume":"71","author":"Lumachi","year":"2005","journal-title":"Am Surg"},{"key":"10.1016\/j.hlc.2013.01.006_bib0130","first-page":"1141","article-title":"The blood pressure response to unilateral adrenalectomy in primary aldosteronism","volume":"61","author":"Milsom","year":"1986","journal-title":"Q J Med"},{"key":"10.1016\/j.hlc.2013.01.006_bib0135","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1210\/jc.2009-1763","article-title":"Improved quality of life, blood pressure, and biochemical status following laparoscopic adrenalectomy for unilateral primary aldosteronism","volume":"95","author":"Sukor","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.hlc.2013.01.006_bib0140","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1517\/14656566.9.4.509","article-title":"Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism","volume":"9","author":"Karagiannis","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.hlc.2013.01.006_bib0145","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1161\/01.CIR.83.6.1849","article-title":"Pathological hypertrophy and cardiac interstitium. Fibrosis and renin\u2013angiotensin\u2013aldosterone system","volume":"83","author":"Weber","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2013.01.006_bib0150","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0895-7061(02)03021-2","article-title":"Left ventricular changes in primary aldosteronism","volume":"16","author":"Rossi","year":"2003","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.hlc.2013.01.006_bib0155","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1210\/jc.2011-0354","article-title":"Cardiac dimensions are largely determined by dietary salt in patients with primary aldosteronism: results of a case\u2013control study","volume":"96","author":"Pimenta","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.hlc.2013.01.006_bib0160","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.HYP.0000052542.68896.2B","article-title":"Myocardial ultrasonic backscatter in hypertension: relation to aldosterone and endothelin","volume":"41","author":"Kozakova","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.hlc.2013.01.006_bib0165","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1097\/HJH.0b013e32831286fd","article-title":"Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism","volume":"26","author":"Bernini","year":"2008","journal-title":"J Hypertens"},{"key":"10.1016\/j.hlc.2013.01.006_bib0170","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1097\/HJH.0b013e3281268532","article-title":"Increased intima-media thickness of the common carotid artery in primary aldosteronism in comparison with essential hypertension","volume":"25","author":"Holaj","year":"2007","journal-title":"J Hypertens"},{"key":"10.1016\/j.hlc.2013.01.006_bib0175","doi-asserted-by":"crossref","DOI":"10.1507\/endocrj.K09E-014","article-title":"Endothelial dysfunction is related to aldosterone excess and raised blood pressure","author":"Tsuchiya","year":"2009","journal-title":"Endocr J"},{"key":"10.1016\/j.hlc.2013.01.006_bib0180","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","article-title":"Cardiovascular outcomes in patients with primary aldosteronism after treatment","volume":"168","author":"Catena","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.hlc.2013.01.006_bib0185","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2013.01.006_bib0190","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1161\/HYPERTENSIONAHA.112.197111","article-title":"Observational study mortality in treated primary aldosteronism: the German Conn's registry","volume":"60","author":"Reincke","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.hlc.2013.01.006_bib0195","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1210\/jc.2005-0681","article-title":"Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I","volume":"90","author":"Stowasser","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.hlc.2013.01.006_bib0200","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1161\/HYPERTENSIONAHA.108.128512","article-title":"Elevated serum interleukin 6 levels in normotensive individuals with familial hyperaldosteronism type 1","volume":"53","author":"Staermose","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.hlc.2013.01.006_bib0205","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/ajh.2008.243","article-title":"Adrenalectomy improves arterial stiffness in primary aldosteronism","volume":"21","author":"Strauch","year":"2008","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.hlc.2013.01.006_bib0210","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.107.095448","article-title":"Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism","volume":"50","author":"Catena","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.hlc.2013.01.006_bib0215","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.0000230444.01215.6a","article-title":"Renal damage in primary aldosteronism: results of the PAPY Study","volume":"48","author":"Rossi","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.hlc.2013.01.006_bib0220","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1210\/jc.2008-2245","article-title":"Intrarenal hemodynamics in primary aldosteronism before and after treatment","volume":"94","author":"Sechi","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.hlc.2013.01.006_bib0225","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/jhh.2010.102","article-title":"Unilateral adrenalectomy improves urinary protein excretion but does not abolish its relationship to sodium excretion in patients with aldosterone-producing adenoma","volume":"25","author":"Pimenta","year":"2011","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.hlc.2013.01.006_bib0230","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.pcad.2008.02.004","article-title":"Sleep apnea, aldosterone, and resistant hypertension","volume":"51","author":"Pimenta","year":"2009","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.hlc.2013.01.006_bib0235","first-page":"537","article-title":"Primary hyperaldosteronism and depression","volume":"97","author":"Avery","year":"1984","journal-title":"N Z Med J"},{"key":"10.1016\/j.hlc.2013.01.006_bib0240","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1176\/appi.ajp.162.6.1226","article-title":"Conn's syndrome presenting as depression","volume":"162","author":"Khurshid","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.hlc.2013.01.006_bib0245","first-page":"358","article-title":"Hyperaldosteronism (Conn's disease) presenting as depression","volume":"40","author":"Malinow","year":"1979","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.hlc.2013.01.006_bib0465","doi-asserted-by":"crossref","first-page":"E878","DOI":"10.1210\/jc.2010-2723","article-title":"Psychological assessment of primary aldosteronism: a controlled study","volume":"96","author":"Sonino","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.hlc.2013.01.006_bib0250","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000323618","article-title":"Episodic rage associated with primary aldosteronism resolved with adrenalectomy","volume":"80","author":"Houlihan","year":"2011","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.hlc.2013.01.006_bib0255","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1210\/jc.2011-0138","article-title":"Quality of life in patients with bilateral primary aldosteronism before and during treatment with spironolactone and\/or amiloride, including a comparison with our previously published results in those with unilateral disease treated surgically","volume":"96","author":"Ahmed","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.hlc.2013.01.006_bib0260","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1006\/bbrc.1995.1225","article-title":"A new genetic test for familial hyperaldosteronism type I aids in the detection of curable hypertension","volume":"207","author":"Jonsson","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.hlc.2013.01.006_bib0265","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/355262a0","article-title":"A chimaeric 11 beta-hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension","volume":"355","author":"Lifton","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.hlc.2013.01.006_bib0270","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S1043-2760(98)00058-7","article-title":"Familial forms broaden horizons in primary aldosteronism","volume":"9","author":"Gordon","year":"1998","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.hlc.2013.01.006_bib0275","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2265.1991.tb00306.x","article-title":"Histological and biochemical distinctiveness of atypical aldosterone-producing adenomas responsive to upright posture and angiotensin","volume":"34","author":"Tunny","year":"1991","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.hlc.2013.01.006_bib0280","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/00004872-200405000-00001","article-title":"The current epidemic of primary aldosteronism: causes and consequences","volume":"22","author":"Kaplan","year":"2004","journal-title":"J Hypertens"},{"key":"10.1016\/j.hlc.2013.01.006_bib0285","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1097\/HJH.0b013e3283559a03","article-title":"Primary aldosteronism: evidence against a second epidemic","volume":"30","author":"Kaplan","year":"2012","journal-title":"J Hypertens"},{"key":"10.1016\/j.hlc.2013.01.006_bib0290","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1055\/s-0031-1301281","article-title":"Primary aldosteronism: are we missing the wood for the trees?","volume":"44","author":"Funder","year":"2012","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.hlc.2013.01.006_bib0295","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1097\/HJH.0b013e328356c5be","article-title":"Ultimately we are in furious agreement","volume":"30","author":"Funder","year":"2012","journal-title":"J Hypertens"},{"key":"10.1016\/j.hlc.2013.01.006_bib0300","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1210\/jc.2011-2830","article-title":"The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism","volume":"97","author":"Rossi","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.hlc.2013.01.006_bib0305","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1161\/HYPERTENSIONAHA.110.168484","article-title":"Adrenal venous sampling: evaluation of the German Conn's registry","volume":"57","author":"Vonend","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.hlc.2013.01.006_bib0310","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline","volume":"93","author":"Funder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.hlc.2013.01.006_bib0315","first-page":"1109","article-title":"Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone","volume":"95","author":"Sutherland","year":"1966","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.hlc.2013.01.006_bib0320","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1172\/JCI118279","article-title":"Glucocorticoid-suppressible hyperaldosteronism and adrenal tumors occurring in a single French pedigree","volume":"96","author":"Pascoe","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hlc.2013.01.006_bib0325","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.3109\/10641968209061640","article-title":"Hypersecretion of a new corticosteroid, 18-hydroxycortisol in two types of adrenocortical hypertension","volume":"4","author":"Ulick","year":"1982","journal-title":"Clin Exp Hypertens A"},{"key":"10.1016\/j.hlc.2013.01.006_bib0330","doi-asserted-by":"crossref","first-page":"813","DOI":"10.7326\/0003-4819-116-10-813","article-title":"Glucocorticoid-remediable aldosteronism in a large kindred: clinical spectrum and diagnosis using a characteristic biochemical phenotype","volume":"116","author":"Rich","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hlc.2013.01.006_bib0335","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1445-5994.1997.tb00999.x","article-title":"A PCR-based method of screening individuals of all ages, from neonates to the elderly, for familial hyperaldosteronism type I","volume":"27","author":"Stowasser","year":"1997","journal-title":"Aust N Z J Med"},{"key":"10.1016\/j.hlc.2013.01.006_bib0340","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1210\/jc.85.9.3313","article-title":"Treatment of familial hyperaldosteronism type I: only partial suppression of adrenocorticotropin required to correct hypertension","volume":"85","author":"Stowasser","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.hlc.2013.01.006_bib0345","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1210\/jc.83.7.2573","article-title":"Diagnosis of glucocorticoid-remediable aldosteronism in primary aldosteronism: aldosterone response to dexamethasone and long polymerase chain reaction for chimeric gene","volume":"83","author":"Mulatero","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.hlc.2013.01.006_bib0350","first-page":"1610","article-title":"Clinical, biochemical and genetic approaches to the detection of familial hyperaldosteronism type I","volume":"13","author":"Stowasser","year":"1995","journal-title":"J Hypertens"},{"key":"10.1016\/j.hlc.2013.01.006_bib0355","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1440-1681.1991.tb01446.x","article-title":"Clinical and pathological diversity of primary aldosteronism, including a new familial variety","volume":"18","author":"Gordon","year":"1991","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.hlc.2013.01.006_bib0360","doi-asserted-by":"crossref","first-page":"S264","DOI":"10.1097\/00004872-199112006-00116","article-title":"Primary aldosteronism: implications of a new familial variety","volume":"9","author":"Stowasser","year":"1991","journal-title":"J Hypertens Suppl"},{"key":"10.1016\/j.hlc.2013.01.006_bib0365","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1440-1681.1992.tb00462.x","article-title":"Familial hyperaldosteronism type II: five families with a new variety of primary aldosteronism","volume":"19","author":"Stowasser","year":"1992","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.hlc.2013.01.006_bib0370","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ecl.2011.01.007","article-title":"Familial or genetic primary aldosteronism and Gordon syndrome","volume":"40","author":"Stowasser","year":"2011","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.hlc.2013.01.006_bib0375","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1043-2760(03)00112-7","article-title":"Primary aldosteronism: from genesis to genetics","volume":"14","author":"Stowasser","year":"2003","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.hlc.2013.01.006_bib0380","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1136\/jmg.37.11.831","article-title":"A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22)","volume":"37","author":"Lafferty","year":"2000","journal-title":"J Med Genet"},{"key":"10.1016\/j.hlc.2013.01.006_bib0385","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1097\/01.hjh.0000174299.66369.26","article-title":"Familial hyperaldosteronism type II is linked to the chromosome 7p22 region but also shows predicted heterogeneity","volume":"23","author":"So","year":"2005","journal-title":"J Hypertens"},{"key":"10.1016\/j.hlc.2013.01.006_bib0390","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1097\/HJH.0b013e3283028352","article-title":"Further evidence for linkage of familial hyperaldosteronism type II at chromosome 7p22 in Italian as well as Australian and South American families","volume":"26","author":"Sukor","year":"2008","journal-title":"J Hypertens"},{"key":"10.1016\/j.hlc.2013.01.006_bib0395","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/01.HYP.0000258554.87444.91","article-title":"Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample","volume":"49","author":"Newton-Cheh","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.hlc.2013.01.006_bib0400","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.1198785","article-title":"K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension","volume":"331","author":"Choi","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.hlc.2013.01.006_bib0405","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1210\/jc.2008-0594","article-title":"A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism","volume":"93","author":"Geller","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.hlc.2013.01.006_bib0410","doi-asserted-by":"crossref","first-page":"e41926","DOI":"10.1371\/journal.pone.0041926","article-title":"Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter","volume":"7","author":"Akerstrom","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.hlc.2013.01.006_bib0415","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/HYPERTENSIONAHA.111.186239","article-title":"Somatic mutations affecting the selectivity filter of KCNJ5 are frequent in 2 large unselected collections of adrenal aldosteronomas","volume":"59","author":"Azizan","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.hlc.2013.01.006_bib0420","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/HYPERTENSIONAHA.111.186478","article-title":"Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism","volume":"59","author":"Boulkroun","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.hlc.2013.01.006_bib0425","doi-asserted-by":"crossref","first-page":"E1567","DOI":"10.1210\/jc.2011-3132","article-title":"Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells","volume":"97","author":"Monticone","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.hlc.2013.01.006_bib0430","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1210\/jc.2011-2885","article-title":"Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas","volume":"97","author":"Taguchi","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.hlc.2013.01.006_bib0435","doi-asserted-by":"crossref","first-page":"E1532","DOI":"10.1210\/jc.2012-1334","article-title":"A novel point mutation in the KCNJ5 gene causing primary hyperaldosteronism and early-onset autosomal dominant hypertension","volume":"97","author":"Charmandari","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.hlc.2013.01.006_bib0440","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/HYPERTENSIONAHA.111.183996","article-title":"KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism","volume":"59","author":"Mulatero","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.hlc.2013.01.006_bib0445","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1073\/pnas.1121407109","article-title":"Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5","volume":"109","author":"Scholl","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.hlc.2013.01.006_bib0450","doi-asserted-by":"crossref","first-page":"E819","DOI":"10.1210\/jc.2011-2965","article-title":"Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors","volume":"97","author":"Azizan","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.hlc.2013.01.006_bib0455","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1210\/en.2011-1733","article-title":"Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis","volume":"153","author":"Oki","year":"2012","journal-title":"Endocrinology"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950613000267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950613000267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T07:33:39Z","timestamp":1644305619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950613000267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":92,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S1443950613000267"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2013.01.006","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}